Iaryna Iosyk

Iaryna Iosyk


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2020 in Інфекційні хвороби
Verified
Journal Article
Open access
PDF file
MAM. A. Andreychyn
M. A. Andreychyn
NNN. A. Nychyk
N. A. Nychyk
NZN. H. Zavidniuk
N. H. Zavidniuk
IIIaryna Iosyk
Iaryna Iosyk
III. S. Ischuk
I. S. Ischuk
OIO. L. Ivakhiv
O. L. Ivakhiv
На підставі огляду наукової літератури наведено основні дані про історію коронавірусних інфекцій людини, зокрема епідемії тяжкого гострого респіраторного синдрому (SARS) і близько-східного респіраторного синдрому (MERS) та теперішню пандемію COVID-19. Послідовно описано етіологію COVID-19, її епідеміологію, патогенез, основні клінічні варіанти та їх прояви, класифікацію за ступенем тяжкості, можливі ускладнення та обтяжливі чинники. Подано визначення різних випадків цієї інфекції за епідеміологічними та клінічними критеріями. Перечислено лабораторні та апаратні методи діагностики з клінічним тлумаченням. Виокремлено методи специфічної та диференційної діагностики. Наведено показання до госпіталізації хворих на COVID-19 і сучасні підходи до лікування за відсутності специфічних противірусних засобів. У лікуванні акцент зроблено на застосуванні патогенетичної терапії. Стисло наведено основні заходи неспецифічної індивідуальної та колективної профілактики із запровадженням карантину. Стаття призначена головно для лікарів, які працюють з хворими на COVID-19 і контактними особами.

19 May 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NMNataliia Melnichuk
Nataliia Melnichuk
Vladimir V. ZarubaevVladimir V. Zarubaev
Vladimir V. Zarubaev
IIIaryna Iosyk
Iaryna Iosyk
MAMychaylo Andreychyn
Mychaylo Andreychyn
LSLarisa Semernikova
Larisa Semernikova
ZTZenoviy Tkachuk
Zenoviy Tkachuk
Oligoribonucleotides-D-mannitol (ORNs-D-M) complexes possess antiviral, anti-inflammatory, and immunomodulatory actions. The aim of the present study was to evaluated an antiviral effect of ORNs-D-M against parainfluenza virus type 3 (PIV3); influenza CA709, PR834; avian influenza virus H5N2 (AIV) in vitro by a TCID50; hemadsorption and neuraminidase activity assays; and clinical efficiency of ORNs-D-M in patients with acute respiratory infections (ARIs) of various etiologies by PCR assay and AmpliSens test systems. It was observed that ORNs-D-M have an antiviral activity against the influenza CA709, PR834, PIV3, and AIV in vitro. The injectable dosage form of ORNs-D-M was shown to have a stronger antiviral effect compared to capsule form. It was also detected that the injectable form of ORNs-D-M significantly reduced the neuraminidase activity of influenza PR834. A complex treatment of patients with ORNs-D-M had a positive effect on the course of the disease, it accelerated patients’ recovery. Treatment with ORNs-D-M caused eradication of adeno- and influenza viruses in patients with ARI. This drug contributed to significant decrease in duration of febrile period and cough. Comprehensive treatment with ORNs-D-M improved the disease clinical findings significantly. Collectively, these results suggested that ORNs-D-M may be used at co-infection with influenza and other respiratory viruses as a medical antiviral drug.

23 December 2017 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
NVNatalia Vasylieva
Natalia Vasylieva
MAMykhaylo Andreychyn
Mykhaylo Andreychyn
YKYulia Kravchuk
Yulia Kravchuk
ОCОlena Chervinska
Оlena Chervinska
IIIaryna Iosyk
Iaryna Iosyk
Introduction: Leptospirosis is endemic in Ternopil region. In Ukraine, the disease is registered in almost all regions, including the Ternopil region. The aim of the research is to study the regularities of epidemic and epizootic processes of leptospirosis, and the circulation of its pathogens...

30 September 2024 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
MAMykchaylo Andreychyn
Mykchaylo Andreychyn
LMLarysa Melnyk
Larysa Melnyk
NZNataliia Zavidniiuk
Nataliia Zavidniiuk
NNNatalya Nychyk
Natalya Nychyk
IIIaryna Iosyk
Iaryna Iosyk
Influenza and other acute respiratory viral infections (ARVIs) are among the most common human diseases. In recent decades, the discovery of cytokines and their significance in the pathogenesis of diseases has led to extensive research on these compounds in various pathologies including ARVIs. The aim of the research was to study the cytokine profile in patients with ARVIs. The cases of 30 patients were investigated. Etiological diagnosis was performed by polymerase chain reaction. Different classes of cytokines in the serum were defined by the enzyme-linked immunosorbent assay (ELISA). The level of cytokines depended on the number of pathogens. The highest levels of pro-inflammatory interleukins and the lowest levels of anti-inflammatory IL-4 were observed in patients with a combination of five or more viruses compared to those with a monoinfection. Analysis of the data showed that in the acute phase, the levels of all studied pro-inflammatory cytokines – IL-2, IL-6, and TNF-α – increased by 8, 39, and 9 times, respectively, compared to those in healthy individuals. In the acute phase of ARVI, the levels of pro-inflammatory cytokines were significantly higher and depended on the severity of the disease. The imbalance of cytokines in the serum has been established in cases of ARVIs, depending on the severity of the disease.

15 October 2025 in Military Medicine
Verified
Journal Article
Closed access
OIOleh Ivakhiv
Oleh Ivakhiv
NVNataliya Vyshnevska
Nataliya Vyshnevska
IIIaryna Iosyk
Iaryna Iosyk
YVYulia Vyshnevska
Yulia Vyshnevska
NZNataliia Zavidniuk
Nataliia Zavidniuk
In recent years, the incidence of leptospirosis in Ukraine has been increasing because of a number of factors, such as climate change and the ongoing war. The aim of this case report is to present a case of challenging leptospirosis diagnosis in a serviceman. A 38-year-old male, although in a combat zone, repeatedly noted the presence of mice in his deployment locations. He experienced an acute onset of illness with fever, muscle pain, and pronounced general weakness. He self-administered an antibiotic. Subsequently, he developed a cough and shortness of breath upon exertion. He was hospitalized with a diagnosis of pneumonia. Klebsiella pneumoniae was isolated from his sputum. He was successively prescribed cefepime and meropenem, but no clinical improvement was observed: fever, cough, and CT changes were still present. As the infiltrative focus was localized in the right upper lobe, differential diagnosis with tuberculosis was performed. Sputum PCR and repeated CT allowed excluding tuberculosis. Because of persistent fever, myalgia, development of polyuria, and taking into account his epidemiological history, the patient was additionally tested for leptospirosis. The diagnosis of leptospirosis was verified by detecting specific serum antibodies by the microagglutination lysis reaction with a dynamic increase in their titer. The patient’s condition improved after prescribing piperacillin-tazobactam, to which leptospiras were sensitive. This clinical case highlights that atypical clinical manifestations and their inadequate assessment can complicate the timely diagnosis of leptospirosis. Servicemen in field conditions are in a risk group for this infection.

1 January 2019 in Journal of Gastroenterology and Hepatology Research
Verified
Journal Article
Open access
PDF file
MAMykhaylo Andreychyn
Mykhaylo Andreychyn
OIOleh Ivakhiv
Oleh Ivakhiv
NVNatalia Vyshnevska
Natalia Vyshnevska
IIIaryna Iosyk
Iaryna Iosyk
Introduction: Chronic hepatitis C (CHC) is a topical medical and social issue in Ukraine, despite of the high effectiveness of present antiviral therapy (AVT). The aim of the research is to evaluate the virological and morphological effectiveness of various therapeutic regimens of AVT in cases of CHC. Materials and methods: 160 patients with CHC underwent AVT. Liver fibrosis (F) was evaluated using a fibro-test before and after treatment. According to the AVT therapeutic regimens the patients were divided into the following groups: group 1 (51 patients) - pegylated interferon-α (PEG-IFN) and ribavirin for 24-48 weeks; group 2 (34 patients) - sofosbuvir as well for 12 weeks; group 3 (74 patients) no PEG-IFN 12-week therapeutic regimen: sofosbuvir and ribavirin (2 patients), direct antiviral drugs (DAD): sofosbuvir and lepipasvir (48 patients), sofosbuvir and daclatasvir (11 patients), and ribavirin as well (9 patients) for 24 weeks, sofosbuvir and velpatasvir (3 patients), together with ribavirin (1 patient), 3D therapy (ombitasvir/paritaprevir/ritonavir + dasabuvir) (1 patient). Results: In the group 1, a stable viral response (SVR) in 12 and 24 weeks was evidenced in 78.4% of the patients, in the group 2 - in 97.0%, in the group 3 - in 98.7%. A number of people with the most severe inflammatory and necrotic processes in the liver fibrosis (F3) decreased from 41.6 to 9.7% (p < 0.02) at the end of the treatment in the presence of a significantly increased frequency of F0 (up to 84.6%). After treatment, in 61 examined patients, liver fibrosis reduction was evidenced in 54.1%, in 36.1% the degree of fibrosis did not change, and in 9.8% - fibrosis expansion was present. Conclusions: Eradication of HCV does not ensure further progression of liver fibrosis.